FDA
-
-
-
-
-
-
-
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates
-
-
-
-
-
-
-
Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update
-
-
-
-
-
-
-
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
-
-
-
-
-
-
-
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
-
-
-
-
-
-
-
Evofem Biosciences (EVFM) Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt (ADTX)
-
-
-
-
-
-
-
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
-
-
-
-
-
-
-
Evofem Biosciences (EVFM) Strengthens Phexxi Intellectual Property
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

